Related Experiment Videos
Isosafrole and schizophrenia-like psychosis
The American Journal of Psychiatry
|August 1, 1984
Abstract:
A 19-year-old man developed a schizophrenia-like psychosis after ingesting isosafrole. His use of amphetamines and LSD failed to produce a similar syndrome. Isosafrole may provide another biochemical model for schizophrenia.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Drug-induced akathisia: subjective experience and objective findings.
Military medicine·2010
An adjunctive Management of Depression Program for difficult-to-treat depressed patients and their families.
Depression and anxiety·2009
Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: targets for nonpharmacological intervention.
Journal of Alzheimer's disease : JAD·2007
Youth Autistic Traits and Brain Activation States During Socioemotional Processing.
The American journal of psychiatry·2026
Schizophrenia Beyond Genome-Wide Association Studies: It's About Time.
The American journal of psychiatry·2026
Determinants of Nonspecific Response to Treatment in Randomized Controlled Trials of Major Depressive Disorder: A Narrative Review.
The American journal of psychiatry·2026
Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial.
The American journal of psychiatry·2026
Global Prevalence of Obsessive-Compulsive and Related Disorders: A Systematic Review and Modeling Study.
The American journal of psychiatry·2026
Aptamer-based nanoparticle drug delivery system designed for targeting GPC3-positive liver cancer.
Journal of pharmaceutical analysis·2026
Structure-informed characterization of a TLR2-binding scFv reveals a CDR-centered recognition model.
Biochemical and biophysical research communications·2026
Safety assessment of the substance 1,3-benzenedicarboxamide, 5-[[[cis-4-(1,1-dimethylethyl)cyclohexyl]carbonyl]amino]-N1,N3-bis[cis-4-(1-methylethyl)cyclohexyl]- for use in food contact materials.
EFSA journal. European Food Safety Authority·2026
Systems pharmacology, structural modeling, and experimental validation reveal retinoic acid as a modulator of immune-fibrotic networks in chronic kidney disease.
Naunyn-Schmiedeberg's archives of pharmacology·2026
New paradigm of q-CAR drug development targeting disease-specific protein conformations.
npj drug discovery·2026